Form D · Other Health Care
StataDx, Inc.
Boston, MA · CIK 0001909462
Offering snapshot reported Apr 7, 2026 · SEC filing
- Reported sold
- $1.89M Offering amount: $2.49M
- Investors reported
- 7 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 27, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 7, 2026 | Initial | $1,891,500 | No comparison | 7 | SEC filing |
| Mar 21, 2024 | Initial | $1,790,000 | No comparison | 5 | SEC filing |
| Feb 7, 2022 | Initial | $2,700,000 | No comparison | 5 | SEC filing |
Offering details
- Securities
- Equity, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-579428
Source: Form D, filed Apr 7, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Michal Depa | Executive |
| Donald Ingber | Director |
| Sidhant Jena | Director, Executive |
| Daniel Lookadoo | Executive |
| Amarpreet Sawhney | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
8 St. Mary's St Suite 936
Boston, MA, 02215
Boston, MA, 02215